ロード中...
RET Fusion as a Novel Driver of Medullary Thyroid Carcinoma
INTRODUCTION: Oncogenic RET tyrosine kinase gene fusions and activating mutations have recently been identified in lung cancers, prompting initiation of targeted therapy trials in this disease. Although RET point mutation has been identified as a driver of tumorigenesis in medullary thyroid carcinom...
保存先:
| 出版年: | J Clin Endocrinol Metab |
|---|---|
| 主要な著者: | , , , , , , , , , , , , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Endocrine Society
2015
|
| 主題: | |
| オンライン・アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4333032/ https://ncbi.nlm.nih.gov/pubmed/25546157 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1210/jc.2014-4153 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|